Arizona was the only state that voted against cannabis legalization in the 2016 election, but by the time Modern Grower host Felix Fang got to Arizona, she found a company leading the nation in science- and technology-driven research and production. AltMed Arizona is a next-generation facility that continuously monitors the plants from nursery to harvest, and the state-of-the-art laboratory provides clean extractions, breakthrough research and rigorous testing for safety, quality and accuracy. From seed to sale, the facility handles every aspect of its premiere line of MüV products.
“We have a full portfolio of medical cannabis products under the MüV brand,” explains Todd Beckwith, Director of Marketing. These advanced products include metered-dose inhalers (with equal parts THC and CBD), 12-hour-release transdermal patches, ethanol extraction crumble and award-winning, solvent-free distillate oil.
AltMed holds itself to a higher standard with the belief that the Food and Drug Administration (FDA) will soon recognize the medical value of cannabis, and the company wants to make products now that will meet the government regulatory standards of the near future.
In this episode of Modern Grower, Dr. Chris Witowski, Director of Laboratory Services, also explains the company’s vision to help people. He states, “You learn something new every day about the process, the plant itself, the compounds, the formulation and removing the stigma that’s behind the cannabis plant and really bringing it to the forefront as a medicine. It’s really just a strive for knowledge and a strive for greater good.”